The Significance of CAS 62893-24-7 as a Pharmaceutical Intermediate
This chemical, with the molecular formula C15H17N3O6, serves as a foundational component in the creation of sophisticated drug molecules. Specifically, it is indispensable for the synthesis of Cephalosporin derivatives. These antibiotics are a cornerstone of modern medicine, providing broad-spectrum coverage against a multitude of bacterial pathogens. The precise structural attributes of CAS 62893-24-7 are key to the efficacy and safety profile of the final antibiotic products.
NINGBO INNO PHARMCHEM CO.,LTD. specializes in the production and supply of high-quality pharmaceutical intermediates. We understand that the integrity of the final drug product is directly linked to the quality of the raw materials used. Therefore, we maintain rigorous quality control throughout our manufacturing process to ensure that our (2R)-2-[(4-Ethyl,2,3-dioxopiperazinyl)carbonylamino]-2-(4-hydroxyphenyl)acetic acid meets the highest industry standards. Our commitment extends to providing a stable and reliable supply chain, ensuring that our clients, including those in Antibiotic Production, can meet their production demands consistently.
For any pharmaceutical company or research institution engaged in the development of new antibiotics or seeking reliable sources for established drug manufacturing, partnering with NINGBO INNO PHARMCHEM CO.,LTD. offers a distinct advantage. We are dedicated to supporting advancements in healthcare by providing superior chemical building blocks. When you need a trusted China manufacturer for your pharmaceutical intermediate requirements, look to NINGBO INNO PHARMCHEM CO.,LTD. for unparalleled quality and service.
Perspectives & Insights
Chem Catalyst Pro
“The precise structural attributes of CAS 62893-24-7 are key to the efficacy and safety profile of the final antibiotic products.”
Agile Thinker 7
“specializes in the production and supply of high-quality pharmaceutical intermediates.”
Logic Spark 24
“We understand that the integrity of the final drug product is directly linked to the quality of the raw materials used.”